SEC Form 4 insider trading filings tracked in real time from EDGAR

KAKKIS EMIL D — President & CEO

Insider trading activity for KAKKIS EMIL D sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: President & CEO
  • Company: Ultragenyx Pharmaceutical Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Apr 20, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Apr 16, 2026 KAKKIS EMIL D RARE Ultragenyx Pharmaceutical Inc. BUY 132,693 N/A
Apr 16, 2026 KAKKIS EMIL D RARE Ultragenyx Pharmaceutical Inc. BUY 76,745 N/A

← All executives · Full trades feed